A Comparison of Clinical FISH and Sequencing Based FISH Estimates in Multiple Myeloma: An Mmrf Commpass Analysis

被引:9
|
作者
Miller, Chase [1 ]
Yesil, Jennifer [2 ]
Derome, Mary [2 ]
Donnelly, Andrea [3 ]
Marrian, Jean [3 ]
McBride, Kyle [4 ]
Auclair, Daniel [2 ]
Keats, Jonathan J. [5 ]
机构
[1] TGen, Phoenix, AZ USA
[2] Multiple Myeloma Res Fdn, Norwalk, CT USA
[3] Precis Oncol, Flemington, NJ USA
[4] Instat Serv, Chatham, NJ USA
[5] Translat Genom Res Inst, Phoenix, AZ USA
关键词
D O I
10.1182/blood.V128.22.374.374
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
374
引用
收藏
页数:4
相关论文
共 50 条
  • [21] Comparative Analysis of Gene Expression Status to Predict Response to Initial Multiple Myeloma Treatment: Utility of the Mmrf Commpass Database in Validating Historical Findings
    Paulus, Aneel
    Coignet, Marie
    Manna, Alak
    Sharma, Mayank
    Sher, Taimur
    Roy, Vivek
    Chanan-Khan, Asher A.
    Ailawadhi, Sikander
    BLOOD, 2017, 130
  • [22] External validation of the simplified score to predict early relapse in multiple myeloma (S-ERMM) in the MMRF CoMMpass dataset
    Slade, Michael
    Fiala, Mark
    Kelley, Sarah
    Crees, Zachary
    Schroeder, Mark
    Stockerl-Goldstein, Keith
    Vij, Ravi
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S20 - S21
  • [23] Identification and Molecular Characterization of High-Risk Multiple Myeloma Patients from the MMRF CoMMpass Study at Diagnosis and Progression
    Skerget, Sheri
    Christofferson, Austin
    Nasser, Sara
    Legendre, Christophe
    Yesil, Jennifer
    Auclair, Daniel
    Lonial, Sagar
    Keats, Jonathan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E7 - E7
  • [24] Multiple myeloma and FISH (but no CHIPS)
    Fonseca, Rafael
    BLOOD, 2007, 109 (08) : 3132 - 3133
  • [25] Clonal Evolution in Newly Diagnosed Multiple Myeloma Patients: A Follow-up Study from the Mmrf Commpass Genomics Project
    Lagana, Alessandro
    Melnekoff, David
    Beno, Itai
    Leshchenko, Violetta
    Perumal, Deepak
    Keats, Jonathan J.
    DeRome, Mary
    Yesil, Jennifer
    Auclair, Daniel
    Madduri, Deepu
    Chari, Ajai
    Cho, Hearn Jay
    Barlogie, Bart
    Jagannath, Sundar
    Dudley, Joel
    Parekh, Samir
    BLOOD, 2017, 130
  • [26] Identifying High-Risk Phenotypes Using Three-Way Feature Interactions in Multiple Myeloma: An Analysis of Publically Available Mmrf Commpass Study
    Stein, Caleb K.
    Asmann, Yan
    Bergsagel, P. Leif
    BLOOD, 2017, 130
  • [27] Clinical and Genomics Characteristics of Multiple Myeloma with Extramedullary Disease in the Mmrf Registry
    Saldarriaga, Mateo Mejia
    Jayabalan, David S.
    Sowa, Aubrie
    Monge, Jorge
    Rosenbaum, Cara A.
    Pearse, Roger
    Niesvizky, Ruben
    Patel, Sanjay
    Bustoros, Mark
    BLOOD, 2022, 140 : 4238 - 4239
  • [28] Incidence of serious adverse events in bortezomib, lenalidomide and bortezomib plus lenalidomide maintenance for multiple myeloma: Interim analysis of MMRF-CoMMpass study.
    Vosuri, Venkata
    Fiala, Mark A.
    Ballard, Wenners
    Wildes, Tanya Marya
    Schroeder, Mark A.
    Vij, Ravi
    Stockerl-Goldstein, Keith
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [29] Interphase FISH in multiple myeloma.
    Haaber, Jacob
    Sorensen, Anne G.
    Nibe, Anne
    Nielsen, Ole
    Abildgaard, Niels
    Plesner, Torben
    Kerndrup, Gitte B.
    BLOOD, 2006, 108 (11) : 344B - 344B
  • [30] Cytogenetic and FISH analyses of multiple myeloma
    Nilsson, T
    Hoglund, M
    Westin, J
    Mitelman, F
    Johansson, B
    CYTOGENETICS AND CELL GENETICS, 1999, 85 (1-2): : 81 - 82